MAPT and Alzheimer disease: Studies in human AD patients showed positive correlations between regional susceptibility and tau positron emission tomography (tau-PET) standardized uptake value ratios in the basal ganglia and cortices (Cogswell et al., 2021;Spotorno et al., 2020), which were partly attributed to co-localization of iron or off-target binding of tau PET ligands.